“专利药”的终结?对监管排他性兴起的思考。

IF 0.3 4区医学 Q4 FOOD SCIENCE & TECHNOLOGY

Food and drug law journal Pub Date : 2015-01-01

John R Thomas

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

The End of "Patent Medicines"? Thoughts on the Rise of Regulatory Exclusivities.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Food and drug law journal 医学-食品科技

CiteScore

0.20

自引率

50.00%

发文量

审稿时长

>36 weeks

期刊介绍： The Food and Drug Law Journal is a peer-reviewed quarterly devoted to the analysis of legislation, regulations, court decisions, and public policies affecting industries regulated by the U.S. Food and Drug Administration (FDA) and related agencies and authorities, including the development, manufacture, marketing, and use of drugs, medical devices, biologics, food, dietary supplements, cosmetics, veterinary, tobacco, and cannabis-derived products. Building on more than 70 years of scholarly discourse, since 2015, the Journal is published in partnership with the Georgetown University Law Center and the O’Neill Institute for National & Global Health Law. All members can access the Journal online. Each member organization and most individual memberships (except for government, student, and Emeritus members) receive one subscription to the print Journal.